178 related articles for article (PubMed ID: 18651821)
21. Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system.
Machens A; Dralle H
Ann Surg; 2013 Feb; 257(2):323-9. PubMed ID: 22968075
[TBL] [Abstract][Full Text] [Related]
22. Hepatic metastases from the spindle cell variant of medullary thyroid carcinoma: report of a case with diagnosis by fine needle aspiration biopsy.
Ibarrola de Andrés C; Castellano Megías VM; Ballestin Carcavilla C; Alberti Masgrau N; Perez Barrios A; De Agustín PA
Acta Cytol; 2001; 45(6):1022-6. PubMed ID: 11726097
[TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinase 2 (TIMP-2) in medullary thyroid carcinoma: prognostic implications.
Cavalheiro BG; Junqueira CR; Brandão LG
Thyroid; 2008 Aug; 18(8):865-71. PubMed ID: 18651826
[TBL] [Abstract][Full Text] [Related]
24. Long term prognosis of medullary thyroid carcinoma in 39 patients.
Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
[TBL] [Abstract][Full Text] [Related]
25. Hepatic metastases from medullary thyroid carcinoma appearing twelve years after the eradication of primitive tumor: cytological and radiological aspects.
Bonetto S; Pagano F; Bianco R; Soldi S; Nebuloni M; Vago L
Diagn Cytopathol; 1999 Jul; 21(1):43-5. PubMed ID: 10405808
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas.
Erickson LA; Jin L; Nakamura N; Bridges AG; Markovic SN; Lloyd RV
Cancer; 2007 May; 109(10):1965-71. PubMed ID: 17387744
[TBL] [Abstract][Full Text] [Related]
27. Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer.
Santarpia L; Gagel RF; Sherman SI; Sarlis NJ; Evans DB; Hoff AO
Head Neck; 2009 Mar; 31(3):419-23. PubMed ID: 18798312
[TBL] [Abstract][Full Text] [Related]
28. Update on medullary thyroid cancer.
Hu MI; Ying AK; Jimenez C
Endocrinol Metab Clin North Am; 2014 Jun; 43(2):423-42. PubMed ID: 24891170
[TBL] [Abstract][Full Text] [Related]
29. Micromedullary thyroid cancer: how micro is truly micro?
Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
[TBL] [Abstract][Full Text] [Related]
30. Brain metastasis from medullary thyroid carcinoma.
Börcek P; Asa SL; Gentili F; Ezzat S; Kiehl TR
BMJ Case Rep; 2010 Dec; 2010():. PubMed ID: 22802478
[TBL] [Abstract][Full Text] [Related]
31. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
[TBL] [Abstract][Full Text] [Related]
32. Prediction of lateral lymph node metastases in medullary thyroid cancer.
Machens A; Hauptmann S; Dralle H
Br J Surg; 2008 May; 95(5):586-91. PubMed ID: 18300267
[TBL] [Abstract][Full Text] [Related]
33. [Causes of death in patients with medullary cancer of the thyroid. GETC. Groupe d'Etude des Tumeurs à Calcitonine].
Cohen R; Buchsenschutz B; Estrade P; Gardet P; Modigliani E
Presse Med; 1996 Nov; 25(37):1819-22. PubMed ID: 8991034
[TBL] [Abstract][Full Text] [Related]
34. Optic disc and choroidal metastasis from sporadic medullary thyroid carcinoma: case report and review of the literature.
Yildiz I; Sen F; Tuncer S; Kilic L; Basaran M; Bavbek S
Onkologie; 2011; 34(11):630-3. PubMed ID: 22104161
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H
Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514
[TBL] [Abstract][Full Text] [Related]
36. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
[TBL] [Abstract][Full Text] [Related]
37. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
[TBL] [Abstract][Full Text] [Related]
38. Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature.
Avram AM; Gielczyk R; Su L; Vine AK; Sisson JC
J Clin Endocrinol Metab; 2004 Nov; 89(11):5303-7. PubMed ID: 15531474
[TBL] [Abstract][Full Text] [Related]
39. Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer.
Kraeber-Bodéré F; Salaun PY; Oudoux A; Goldenberg DM; Chatal JF; Barbet J
Cancer; 2010 Feb; 116(4 Suppl):1118-25. PubMed ID: 20127952
[TBL] [Abstract][Full Text] [Related]
40. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
